Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Malignant pilomatricoma in a dog with local and distant metastases treated with chemotherapy and bisphosphonates.

Open veterinary journal

Treggiari E, Elliott JW.
PMID: 28795016
Open Vet J. 2017;7(3):208-213. doi: 10.4314/ovj.v7i3.2. Epub 2017 Jul 19.

A ten-year-old male neutered cross breed dog presented for evaluation of a mass associated with the left scapular bone, identified as a carcinoma. The dog had a malignant pilomatricoma removed from the left lateral thigh 6 months earlier. Histopathology...

Cite
Treggiari E, Elliott JW. Malignant pilomatricoma in a dog with local and distant metastases treated with chemotherapy and bisphosphonates. Open Vet J. 2017;7(3):208-213doi: 10.4314/ovj.v7i3.2.
Treggiari, E., & Elliott, J. W. (2017). Malignant pilomatricoma in a dog with local and distant metastases treated with chemotherapy and bisphosphonates. Open veterinary journal, 7(3), 208-213. https://doi.org/10.4314/ovj.v7i3.2
Treggiari, Elisabetta, and Elliott, James W. "Malignant pilomatricoma in a dog with local and distant metastases treated with chemotherapy and bisphosphonates." Open veterinary journal vol. 7,3 (2017): 208-213. doi: https://doi.org/10.4314/ovj.v7i3.2
Treggiari E, Elliott JW. Malignant pilomatricoma in a dog with local and distant metastases treated with chemotherapy and bisphosphonates. Open Vet J. 2017;7(3):208-213. doi: 10.4314/ovj.v7i3.2. Epub 2017 Jul 19. PMID: 28795016; PMCID: PMC5538085.
Copy Download .nbib Format: NLM
Early Pain Exposure Influences Functional Brain Connectivity in Very Preterm Neonates.

Frontiers in neuroscience

Tortora D, Severino M, Di Biase C, Malova M, Parodi A, Minghetti D, Traggiai C, Uccella S, Boeri L, Morana G, Rossi A, Ramenghi LA.
PMID: 31507370
Front Neurosci. 2019 Aug 23;13:899. doi: 10.3389/fnins.2019.00899. eCollection 2019.

BACKGROUND: Early exposure to nociceptive events may cause brain structural alterations in preterm neonates, with long-lasting consequences on neurodevelopmental outcome. Little is known on the extent to which early pain may affect brain connectivity. We aim to evaluate brain...

Cite
Tortora D, Severino M, Di Biase C, et al. Early Pain Exposure Influences Functional Brain Connectivity in Very Preterm Neonates. Front Neurosci. 2019;13:899doi: 10.3389/fnins.2019.00899.
Tortora, D., Severino, M., Di Biase, C., Malova, M., Parodi, A., Minghetti, D., Traggiai, C., Uccella, S., Boeri, L., Morana, G., Rossi, A., & Ramenghi, L. A. (2019). Early Pain Exposure Influences Functional Brain Connectivity in Very Preterm Neonates. Frontiers in neuroscience, 13899. https://doi.org/10.3389/fnins.2019.00899
Tortora, Domenico, et al. "Early Pain Exposure Influences Functional Brain Connectivity in Very Preterm Neonates." Frontiers in neuroscience vol. 13 (2019): 899. doi: https://doi.org/10.3389/fnins.2019.00899
Tortora D, Severino M, Di Biase C, Malova M, Parodi A, Minghetti D, Traggiai C, Uccella S, Boeri L, Morana G, Rossi A, Ramenghi LA. Early Pain Exposure Influences Functional Brain Connectivity in Very Preterm Neonates. Front Neurosci. 2019 Aug 23;13:899. doi: 10.3389/fnins.2019.00899. eCollection 2019. PMID: 31507370; PMCID: PMC6716476.
Copy Download .nbib Format: NLM
DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway.

Oncotarget

Dafflon C, Gaulis S, Barys L, Kapur K, Cornacchione V, Schukur L, Bergling S, Traggiai E, Jansky S, Hellmann L, Engstler BS, Kerr G, de Weck A, Ruddy DA, Naumann U, Stauffer F, Gaul C, Lin Y, Billy E, Weiss A, Hofmann F, Ito M, Tiedt R.
PMID: 32215184
Oncotarget. 2020 Mar 17;11(11):956-968. doi: 10.18632/oncotarget.27493. eCollection 2020 Mar 17.

The histone 3 lysine 79 (H3K79) methyltransferase (HMT) DOT1L is known to play a critical role for growth and survival of

Cite
Dafflon C, Gaulis S, Barys L, et al. DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway. Oncotarget. 2020;11(11):956-968doi: 10.18632/oncotarget.27493.
Dafflon, C., Gaulis, S., Barys, L., Kapur, K., Cornacchione, V., Schukur, L., Bergling, S., Traggiai, E., Jansky, S., Hellmann, L., Engstler, B. S., Kerr, G., de Weck, A., Ruddy, D. A., Naumann, U., Stauffer, F., Gaul, C., Lin, Y., Billy, E., Weiss, A., Hofmann, F., Ito, M., & Tiedt, R. (2020). DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway. Oncotarget, 11(11), 956-968. https://doi.org/10.18632/oncotarget.27493
Dafflon, Caroline, et al. "DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway." Oncotarget vol. 11,11 (2020): 956-968. doi: https://doi.org/10.18632/oncotarget.27493
Dafflon C, Gaulis S, Barys L, Kapur K, Cornacchione V, Schukur L, Bergling S, Traggiai E, Jansky S, Hellmann L, Engstler BS, Kerr G, de Weck A, Ruddy DA, Naumann U, Stauffer F, Gaul C, Lin Y, Billy E, Weiss A, Hofmann F, Ito M, Tiedt R. DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway. Oncotarget. 2020 Mar 17;11(11):956-968. doi: 10.18632/oncotarget.27493. eCollection 2020 Mar 17. PMID: 32215184; PMCID: PMC7082114.
Copy Download .nbib Format: NLM
Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma.

JFMS open reports

Torrigiani F, Romanelli G, Roccabianca P, Treggiari E.
PMID: 31308956
JFMS Open Rep. 2019 Jul 01;5(2):2055116919857870. doi: 10.1177/2055116919857870. eCollection 2019.

CASE SUMMARY: A 7-year old male neutered domestic shorthair cat was presented with a 2 month history of a slow-growing mass on the right zygomatic area. A CT scan revealed a soft tissue mass in the right zygomatic region...

Cite
Torrigiani F, Romanelli G, Roccabianca P, et al. Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma. JFMS Open Rep. 2019;5(2):2055116919857870doi: 10.1177/2055116919857870.
Torrigiani, F., Romanelli, G., Roccabianca, P., & Treggiari, E. (2019). Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma. JFMS open reports, 5(2), 2055116919857870. https://doi.org/10.1177/2055116919857870
Torrigiani, Filippo, et al. "Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma." JFMS open reports vol. 5,2 (2019): 2055116919857870. doi: https://doi.org/10.1177/2055116919857870
Torrigiani F, Romanelli G, Roccabianca P, Treggiari E. Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma. JFMS Open Rep. 2019 Jul 01;5(2):2055116919857870. doi: 10.1177/2055116919857870. eCollection 2019. PMID: 31308956; PMCID: PMC6607568.
Copy Download .nbib Format: NLM
Synthetic Standards Combined With Error and Bias Correction Improve the Accuracy and Quantitative Resolution of Antibody Repertoire Sequencing in Human Naïve and Memory B Cells.

Frontiers in immunology

Friedensohn S, Lindner JM, Cornacchione V, Iazeolla M, Miho E, Zingg A, Meng S, Traggiai E, Reddy ST.
PMID: 29973938
Front Immunol. 2018 Jun 20;9:1401. doi: 10.3389/fimmu.2018.01401. eCollection 2018.

High-throughput sequencing of immunoglobulin (Ig) repertoires (Ig-seq) is a powerful method for quantitatively interrogating B cell receptor sequence diversity. When applied to human repertoires, Ig-seq provides insight into fundamental immunological questions, and can be implemented in diagnostic and drug...

Cite
Friedensohn S, Lindner JM, Cornacchione V, et al. Synthetic Standards Combined With Error and Bias Correction Improve the Accuracy and Quantitative Resolution of Antibody Repertoire Sequencing in Human Naïve and Memory B Cells. Front Immunol. 2018;9:1401doi: 10.3389/fimmu.2018.01401.
Friedensohn, S., Lindner, J. M., Cornacchione, V., Iazeolla, M., Miho, E., Zingg, A., Meng, S., Traggiai, E., & Reddy, S. T. (2018). Synthetic Standards Combined With Error and Bias Correction Improve the Accuracy and Quantitative Resolution of Antibody Repertoire Sequencing in Human Naïve and Memory B Cells. Frontiers in immunology, 91401. https://doi.org/10.3389/fimmu.2018.01401
Friedensohn, Simon, et al. "Synthetic Standards Combined With Error and Bias Correction Improve the Accuracy and Quantitative Resolution of Antibody Repertoire Sequencing in Human Naïve and Memory B Cells." Frontiers in immunology vol. 9 (2018): 1401. doi: https://doi.org/10.3389/fimmu.2018.01401
Friedensohn S, Lindner JM, Cornacchione V, Iazeolla M, Miho E, Zingg A, Meng S, Traggiai E, Reddy ST. Synthetic Standards Combined With Error and Bias Correction Improve the Accuracy and Quantitative Resolution of Antibody Repertoire Sequencing in Human Naïve and Memory B Cells. Front Immunol. 2018 Jun 20;9:1401. doi: 10.3389/fimmu.2018.01401. eCollection 2018. PMID: 29973938; PMCID: PMC6019461.
Copy Download .nbib Format: NLM
An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome.

Frontiers in immunology

Sic H, Speletas M, Cornacchione V, Seidl M, Beibel M, Linghu B, Yang F, Sevdali E, Germenis AE, Oakeley EJ, Vangrevelinghe E, Sailer AW, Traggiai E, Gram H, Eibel H.
PMID: 29375547
Front Immunol. 2017 Dec 15;8:1824. doi: 10.3389/fimmu.2017.01824. eCollection 2017.

Heterozygous mutations in the cytotoxic T lymphocyte antigen-4 (CTLA-4) are associated with lymphadenopathy, autoimmunity, immune dysregulation, and hypogammaglobulinemia in about 70% of the carriers. So far, the incomplete penetrance of CTLA-4 haploinsufficiency has been attributed to unknown genetic modifiers,...

Cite
Sic H, Speletas M, Cornacchione V, et al. An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome. Front Immunol. 2017;8:1824doi: 10.3389/fimmu.2017.01824.
Sic, H., Speletas, M., Cornacchione, V., Seidl, M., Beibel, M., Linghu, B., Yang, F., Sevdali, E., Germenis, A. E., Oakeley, E. J., Vangrevelinghe, E., Sailer, A. W., Traggiai, E., Gram, H., & Eibel, H. (2017). An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome. Frontiers in immunology, 81824. https://doi.org/10.3389/fimmu.2017.01824
Sic, Heiko, et al. "An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome." Frontiers in immunology vol. 8 (2017): 1824. doi: https://doi.org/10.3389/fimmu.2017.01824
Sic H, Speletas M, Cornacchione V, Seidl M, Beibel M, Linghu B, Yang F, Sevdali E, Germenis AE, Oakeley EJ, Vangrevelinghe E, Sailer AW, Traggiai E, Gram H, Eibel H. An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome. Front Immunol. 2017 Dec 15;8:1824. doi: 10.3389/fimmu.2017.01824. eCollection 2017. PMID: 29375547; PMCID: PMC5770691.
Copy Download .nbib Format: NLM
Tolerability and outcome of palliative treatment for metastatic pulmonary carcinoma in cats.

The Journal of small animal practice

Treggiari E, Pellin MA, Valenti P, Curran KM, Borrego JF, Romanelli G, Mason SL, Taylor A.
PMID: 34608648
J Small Anim Pract. 2021 Nov;62(11):992-1000. doi: 10.1111/jsap.13421. Epub 2021 Oct 04.

OBJECTIVES: Pulmonary carcinoma is uncommon in cats and reporting of outcomes following medical treatment is limited, especially in presence of metastases. The aim of this study was to describe the outcome of cats affected by metastatic primary pulmonary carcinoma...

Cite
Treggiari E, Pellin MA, Valenti P, et al. Tolerability and outcome of palliative treatment for metastatic pulmonary carcinoma in cats. J Small Anim Pract. 2021;62(11):992-1000doi: 10.1111/jsap.13421.
Treggiari, E., Pellin, M. A., Valenti, P., Curran, K. M., Borrego, J. F., Romanelli, G., Mason, S. L., & Taylor, A. (2021). Tolerability and outcome of palliative treatment for metastatic pulmonary carcinoma in cats. The Journal of small animal practice, 62(11), 992-1000. https://doi.org/10.1111/jsap.13421
Treggiari, E, et al. "Tolerability and outcome of palliative treatment for metastatic pulmonary carcinoma in cats." The Journal of small animal practice vol. 62,11 (2021): 992-1000. doi: https://doi.org/10.1111/jsap.13421
Treggiari E, Pellin MA, Valenti P, Curran KM, Borrego JF, Romanelli G, Mason SL, Taylor A. Tolerability and outcome of palliative treatment for metastatic pulmonary carcinoma in cats. J Small Anim Pract. 2021 Nov;62(11):992-1000. doi: 10.1111/jsap.13421. Epub 2021 Oct 04. PMID: 34608648.
Copy Download .nbib Format: NLM
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

PLoS pathogens

Caduff N, McHugh D, Murer A, Rämer P, Raykova A, Landtwing V, Rieble L, Keller CW, Prummer M, Hoffmann L, Lam JKP, Chiang AKS, Raulf F, Azzi T, Berger C, Rubic-Schneider T, Traggiai E, Lünemann JD, Kammüller M, Münz C.
PMID: 33347498
PLoS Pathog. 2020 Dec 21;16(12):e1009167. doi: 10.1371/journal.ppat.1009167. eCollection 2020 Dec.

[This corrects the article DOI: 10.1371/journal.ppat.1008477.].

Cite
Caduff N, McHugh D, Murer A, et al. Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS Pathog. 2020;16(12):e1009167doi: 10.1371/journal.ppat.1009167.
Caduff, N., McHugh, D., Murer, A., Rämer, P., Raykova, A., Landtwing, V., Rieble, L., Keller, C. W., Prummer, M., Hoffmann, L., Lam, J. K. P., Chiang, A. K. S., Raulf, F., Azzi, T., Berger, C., Rubic-Schneider, T., Traggiai, E., Lünemann, J. D., Kammüller, M., & Münz, C. (2020). Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS pathogens, 16(12), e1009167. https://doi.org/10.1371/journal.ppat.1009167
Caduff, Nicole, et al. "Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice." PLoS pathogens vol. 16,12 (2020): e1009167. doi: https://doi.org/10.1371/journal.ppat.1009167
Caduff N, McHugh D, Murer A, Rämer P, Raykova A, Landtwing V, Rieble L, Keller CW, Prummer M, Hoffmann L, Lam JKP, Chiang AKS, Raulf F, Azzi T, Berger C, Rubic-Schneider T, Traggiai E, Lünemann JD, Kammüller M, Münz C. Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS Pathog. 2020 Dec 21;16(12):e1009167. doi: 10.1371/journal.ppat.1009167. eCollection 2020 Dec. PMID: 33347498; PMCID: PMC7751847.
Copy Download .nbib Format: NLM
Neonatal Hypoglycemia and Brain Vulnerability.

Frontiers in endocrinology

De Angelis LC, Brigati G, Polleri G, Malova M, Parodi A, Minghetti D, Rossi A, Massirio P, Traggiai C, Maghnie M, Ramenghi LA.
PMID: 33796072
Front Endocrinol (Lausanne). 2021 Mar 16;12:634305. doi: 10.3389/fendo.2021.634305. eCollection 2021.

Neonatal hypoglycemia is a common condition. A transient reduction in blood glucose values is part of a transitional metabolic adaptation following birth, which resolves within the first 48 to 72 h of life. In addition, several factors may interfere...

Cite
De Angelis LC, Brigati G, Polleri G, et al. Neonatal Hypoglycemia and Brain Vulnerability. Front Endocrinol (Lausanne). 2021;12:634305doi: 10.3389/fendo.2021.634305.
De Angelis, L. C., Brigati, G., Polleri, G., Malova, M., Parodi, A., Minghetti, D., Rossi, A., Massirio, P., Traggiai, C., Maghnie, M., & Ramenghi, L. A. (2021). Neonatal Hypoglycemia and Brain Vulnerability. Frontiers in endocrinology, 12634305. https://doi.org/10.3389/fendo.2021.634305
De Angelis, Laura Costanza, et al. "Neonatal Hypoglycemia and Brain Vulnerability." Frontiers in endocrinology vol. 12 (2021): 634305. doi: https://doi.org/10.3389/fendo.2021.634305
De Angelis LC, Brigati G, Polleri G, Malova M, Parodi A, Minghetti D, Rossi A, Massirio P, Traggiai C, Maghnie M, Ramenghi LA. Neonatal Hypoglycemia and Brain Vulnerability. Front Endocrinol (Lausanne). 2021 Mar 16;12:634305. doi: 10.3389/fendo.2021.634305. eCollection 2021. PMID: 33796072; PMCID: PMC8008815.
Copy Download .nbib Format: NLM
Long-term survival in a cat with tonsillar squamous cell carcinoma treated with surgery and chemotherapy.

JFMS open reports

Treggiari E, Romanelli G, Ferro S, Roccabianca P.
PMID: 33614106
JFMS Open Rep. 2021 Feb 05;7(1):2055116920984387. doi: 10.1177/2055116920984387. eCollection 2021.

CASE SUMMARY: A 13-year-old neutered female domestic shorthair cat was presented for further investigation of a right-sided cervical mass. Oral cavity examination revealed a unilateral, right tonsillar mass. Following a contrast-enhanced CT scan of head, thorax and abdomen, which...

Cite
Treggiari E, Romanelli G, Ferro S, et al. Long-term survival in a cat with tonsillar squamous cell carcinoma treated with surgery and chemotherapy. JFMS Open Rep. 2021;7(1):2055116920984387doi: 10.1177/2055116920984387.
Treggiari, E., Romanelli, G., Ferro, S., & Roccabianca, P. (2021). Long-term survival in a cat with tonsillar squamous cell carcinoma treated with surgery and chemotherapy. JFMS open reports, 7(1), 2055116920984387. https://doi.org/10.1177/2055116920984387
Treggiari, Elisabetta, et al. "Long-term survival in a cat with tonsillar squamous cell carcinoma treated with surgery and chemotherapy." JFMS open reports vol. 7,1 (2021): 2055116920984387. doi: https://doi.org/10.1177/2055116920984387
Treggiari E, Romanelli G, Ferro S, Roccabianca P. Long-term survival in a cat with tonsillar squamous cell carcinoma treated with surgery and chemotherapy. JFMS Open Rep. 2021 Feb 05;7(1):2055116920984387. doi: 10.1177/2055116920984387. eCollection 2021. PMID: 33614106; PMCID: PMC7874348.
Copy Download .nbib Format: NLM
Correction to: Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.

BMC pediatrics

Capozza M, Chinellato I, Guarnieri V, Di Iorgi N, Accadia M, Traggiai C, Mattioli G, Di Mauro A, Laforgia N.
PMID: 31771548
BMC Pediatr. 2019 Nov 27;19(1):463. doi: 10.1186/s12887-019-1850-7.

In the published article [1], an error has been noticed in the author group section.

Cite
Capozza M, Chinellato I, Guarnieri V, et al. Correction to: Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation. BMC Pediatr. 2019;19(1):463doi: 10.1186/s12887-019-1850-7.
Capozza, M., Chinellato, I., Guarnieri, V., Di Iorgi, N., Accadia, M., Traggiai, C., Mattioli, G., Di Mauro, A., & Laforgia, N. (2019). Correction to: Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation. BMC pediatrics, 19(1), 463. https://doi.org/10.1186/s12887-019-1850-7
Capozza, Manuela, et al. "Correction to: Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation." BMC pediatrics vol. 19,1 (2019): 463. doi: https://doi.org/10.1186/s12887-019-1850-7
Capozza M, Chinellato I, Guarnieri V, Di Iorgi N, Accadia M, Traggiai C, Mattioli G, Di Mauro A, Laforgia N. Correction to: Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation. BMC Pediatr. 2019 Nov 27;19(1):463. doi: 10.1186/s12887-019-1850-7. PMID: 31771548; PMCID: PMC6880453.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in immunology

Castiello MC, Pala F, Sereni L, Draghici E, Inverso D, Sauer AV, Schena F, Fontana E, Radaelli E, Uva P, Cervantes-Luevano KE, Benvenuti F, Poliani PL, Iannacone M, Traggiai E, Villa A, Bosticardo M.
PMID: 28512459
Front Immunol. 2017 May 02;8:490. doi: 10.3389/fimmu.2017.00490. eCollection 2017.

Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency caused by mutations in the gene encoding the hematopoietic-specific WAS protein (WASp). WAS is frequently associated with autoimmunity, indicating a critical role of WASp in maintenance of tolerance. The role of B...

Cite
Castiello MC, Pala F, Sereni L, et al. . Front Immunol. 2017;8:490doi: 10.3389/fimmu.2017.00490.
Castiello, M. C., Pala, F., Sereni, L., Draghici, E., Inverso, D., Sauer, A. V., Schena, F., Fontana, E., Radaelli, E., Uva, P., Cervantes-Luevano, K. E., Benvenuti, F., Poliani, P. L., Iannacone, M., Traggiai, E., Villa, A., & Bosticardo, M. (2017). . Frontiers in immunology, 8490. https://doi.org/10.3389/fimmu.2017.00490
Castiello, Maria Carmina, et al. "." Frontiers in immunology vol. 8 (2017): 490. doi: https://doi.org/10.3389/fimmu.2017.00490
Castiello MC, Pala F, Sereni L, Draghici E, Inverso D, Sauer AV, Schena F, Fontana E, Radaelli E, Uva P, Cervantes-Luevano KE, Benvenuti F, Poliani PL, Iannacone M, Traggiai E, Villa A, Bosticardo M. . Front Immunol. 2017 May 02;8:490. doi: 10.3389/fimmu.2017.00490. eCollection 2017. PMID: 28512459; PMCID: PMC5411424.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries